On August 1, 2025, Artelo Biosciences, Inc. entered into a Securities Purchase Agreement to raise approximately $9.475 million by selling shares and warrants to accredited investors, with the closing expected on August 5, 2025. The raised funds will support investments in the digital currency Solana (SOL) and general corporate purposes, subject to customary closing conditions.